人間のOAT1の冷凍-EM構造は,薬物結合および抑制メカニズムを明らかにする
Hyung-Min Jeon1, Jisung Eun1, Kelly H Kim2
1Department of Life Sciences, Pohang University of Science and Technology (POSTECH), Pohang 37673, Republic of Korea.
Structure (London, England : 1993)
|August 22, 2025
まとめ
ヒトの有機アニオントランスポーター1 (hOAT1) の構造的な洞察は,オルメサタンのような基板とプロベネシドのような阻害剤がどのように結合するかを明らかにする. これは,輸送メカニズムと潜在的な薬物相互作用を明確にします.
科学分野:
- 生物化学
- 構造生物学
- 薬理学について
背景:
- 有機アニオントランスポーター1 (OAT1) は,薬物の代謝と排出に不可欠です.
- OAT1の構造を理解することは,薬物相互作用を予測する鍵です.
研究 の 目的:
- 人間のOAT1 (hOAT1) による基質と阻害物質の輸送の構造的基礎を解明する.
- hOAT1機能における特定の残留物とイオンの役割を調査する.
主な方法:
- hOAT1の4つの冷凍電子顕微鏡 (cryo-EM) 構造を決定した.
- 分析されたアポ,基板結合 (オルメサタン),および阻害剤結合 (プロベネシド) 形態.
主要な成果:
- 塩化物の調整とオルメサタン輸送における Ser203 の役割を特定した.
- 示された阻害剤は基質の入出を阻害し,保持を増加させる.
- 基板と阻害剤の結合の構造的な違いが明らかになった.
結論:
- OAT1の構造は,基板認識と阻害メカニズムについての洞察を提供します.
- 相互作用が少ない薬の開発に役立つ.
- 塩素イオンはOAT1媒介による輸送において重要な役割を果たします.
さらに関連する動画
09:30Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps
Published on: July 19, 2024
1.5K
18:45Harvesting and Cryo-cooling Crystals of Membrane Proteins Grown in Lipidic Mesophases for Structure Determination by Macromolecular Crystallography
Published on: September 2, 2012
25.2K
関連する概念動画
Cryo-electron Microscopy
3.6K
Conventional electron microscopy (EM) involves dehydration, fixation, and staining of biological samples, which distorts the native state of biological molecules and results in several artifacts. Also, the high-energy electron beam damages the sample and makes it difficult to obtain high-resolution images. These issues can be addressed using cryo-EM, which uses frozen samples and gentler electron beams. The technique was developed by Jacques Dubochet, Joachim Frank, and Richard Henderson, for...
3.6K
Protein-Drug Binding: Mechanism and Kinetics
931
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
931
Gene Families
9.1K
Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
9.1K
Targets for Drug Action: Overview
7.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.4K
Drug Binding to Blood Components
249
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
249
